Dr. Brunner received her PhD at Cambridge University (UK), and post-doctoral training at Columbia University (USA). She joined PsychoGenics in 1999 where she worked for 16 years. As Director, and then Senior VP Behavioral R&D, she developed preclinical tests for cognition, neurodegeneration, autism, between others. She was also heavily involved in the development of PsychoGenics “Cubes.” In the recent past she founded Early Signal and ScienceForward, organizations focused on digital technologies for human health. She has worked closely with many non-profits working in rare disorders, including the Tuberous Sclerosis Alliance, Childrens’ Tumor Foundation, and International Rett syndrome Foundation. She enjoys photography and painting and practices the old disciplines of Kobudo and Iaijutsu.